Community-Level Daytime Sleepiness: Social-Environmental Determinants, Consequences, and Impact of Sleep Apnea
1 other identifier
interventional
28
1 country
1
Brief Summary
The purpose of this study is to examine daytime sleepiness in a community context. This includes examining sleepiness in a large sample in terms of social/behavioral/environmental predictors and health-related outcomes, as well as examining the role of a sleep education intervention in a smaller sample for promoting healthy beliefs/attitudes about sleepiness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2019
CompletedStudy Start
First participant enrolled
November 18, 2019
CompletedFirst Posted
Study publicly available on registry
November 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedDecember 21, 2020
December 1, 2020
8 months
November 8, 2019
December 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Change of Epworth Sleepiness Scale (ESS) score across specific time points for Track 1
ESS is a standard measure to assess daytime sleepiness and consists of 8 items ranging from "No chance of dozing" to "High chance of dozing" that evaluate sleep propensity in a range of situations.
Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to follow up (after 4 weeks).
Change of Epworth Sleepiness Scale (ESS) score across specific time points for Track 2
ESS is a standard measure to assess daytime sleepiness and consists of 8 items ranging from "No chance of dozing" to "High chance of dozing" that evaluate sleep propensity in a range of situations.
Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to pre-intervention (after 4 weeks).
Changes in Sleep Practices and Attitudes Questionnaire (SPAQ) score for Track 1
This questionnaire assesses habitual sleep behaviors associated with sleep and potential sleep problems.
Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to immediately post-intervention (2 hours), and to follow up (after 4 weeks)
Changes in Sleep Practices and Attitudes Questionnaire (SPAQ) score for Track 2
This questionnaire assesses habitual sleep behaviors associated with sleep and potential sleep problems.
Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to pre-intervention (after 4 weeks), and to immediately post-intervention (2 hours)
Changes in Sleep Beliefs Scale (SBS) score for Track 1
The SBS is a revised version of the Sleep Hygiene Awareness and Practice Scale. Possessing a simplified scoring method, the SBS consists of the nine most salient questions from the previous scale, along with 11 relevant additions. The scale requires respondents to indicate how certain behaviors (e.g., drug consumption, daytime and evening activities) can influence the quality and quantity of an individual's sleep, with answers ranging from "positive effect" (on sleep) to "negative effect" (on sleep).
Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to immediately post-intervention (2 hours), and to follow up (after 4 weeks)
Changes in Sleep Beliefs Scale (SBS) score for Track 2
The SBS is a revised version of the Sleep Hygiene Awareness and Practice Scale. Possessing a simplified scoring method, the SBS consists of the nine most salient questions from the previous scale, along with 11 relevant additions. The scale requires respondents to indicate how certain behaviors (e.g., drug consumption, daytime and evening activities) can influence the quality and quantity of an individual's sleep, with answers ranging from "positive effect" (on sleep) to "negative effect" (on sleep).
Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to pre-intervention (after 4 weeks), and to immediately post-intervention (2 hours)
Changes in Dysfunctional Beliefs About Sleep Scale score for Track 1
Consisting of 28 items, the scale evaluates sleep-related beliefs, querying respondents' expectations and attitudes regarding the causes, consequences, and potential treatments of sleep issues, with answers ranging from 0-"Strongly Disagree" to 10-"Strongly Agree".
Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to immediately post-intervention (2 hours), and to follow up (after 4 weeks)
Changes in Dysfunctional Beliefs About Sleep Scale score for Track 2
Consisting of 28 items, the scale evaluates sleep-related beliefs, querying respondents' expectations and attitudes regarding the causes, consequences, and potential treatments of sleep issues, with answers ranging from 0-"Strongly Disagree" to 10-"Strongly Agree".
Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to pre-intervention (after 4 weeks), and to immediately post-intervention (2 hours)
Secondary Outcomes (9)
Qualitative Themes in Sleep Beliefs (Discussed in a group setting)
Focus Group [Day 0]
Demographics and Personal Information
Track 1: Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to follow up (after 4 weeks). Track 2: Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to pre-intervention (after 4 weeks).
Medical History
Track 1: Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to follow up (after 4 weeks). Track 2: Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to pre-intervention (after 4 weeks).
Fatigue Severity Scale (FSS)
Track 1: Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to follow up (after 4 weeks). Track 2: Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to pre-intervention (after 4 weeks).
Sleep Timing Questionnaire (STQ)
Track 1: Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to follow up (after 4 weeks). Track 2: Changes from Baseline (approximately 7 days after Focus Group [Day 0]) to pre-intervention (after 4 weeks).
- +4 more secondary outcomes
Study Arms (2)
Track 1
EXPERIMENTALSubjects will be randomized to one of two 4-week tracks. Track 1 (intervention + follow-up) will consist of the following: Subjects will be randomized to one of two 4-week tracks. Track 1 (intervention + follow-up) will consist of the following: Prior to the session, within 72 hours of the scheduled 2-hour education invention participants will complete a baseline questionnaire battery consisting of measures including demographics, medical history and sleep. After completion, a 2-hour educational presentation will take place with a question-and-answer session. Participants will then complete post-intervention questionnaires to assess immediate impact of the session on knowledge, beliefs and practices. After 4 weeks, Track 1 participants will be contacted and will be asked to re-complete all baseline questionnaires (see above), in order to evaluate changes over 4 weeks.
Track 2
ACTIVE COMPARATORSubjects will be randomized to one of two 4-week tracks. Track 2 (wait list + intervention) will consist of the following: Prior to the session, within 72 hours of the scheduled 2-hour education invention for Track 1 participants will complete the same baseline questionnaire battery. An identical intervention session, scheduled 4 weeks into the future. At that time, an identical procedure to the other track will be followed, including the pretest questionnaires, 2-hour session, and post-session assessment. No additional 4-week follow-up will be performed.
Interventions
Eligibility Criteria
You may qualify if:
- To be included in the study trial, subjects must:
- Subject is a male or female, 20-60 years of age, inclusive.
- Subject is not pregnant.
- Subject obtains a score of \>10 on the Epworth Sleepiness Scale, indicating high daytime sleepiness.
- Subject presents no apparent unstable and/or major medical or psychiatric conditions that may contribute to sleepiness.
- Subject is fluent in English.
- Subject is willing to take part in this study.
You may not qualify if:
- Subject is under the age of 20 or over the age of 60.
- Subject is pregnant.
- Subject presents apparent unstable and/or major medical or psychiatric conditions that may contribute to sleepiness.
- Subject is not fluent in English.
- Subject obtained a score of \<10 on the Epworth Sleepiness Scale.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Arizonalead
- Jazz Pharmaceuticalscollaborator
Study Sites (1)
University of Arizona Department of Psychiatry Research Facilities
Tucson, Arizona, 85724, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael A. Grandner, PhD, MTR
University of Arizona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- All 28 participants will be randomized to one of two 4-week tracks (N=14 each).
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Psychiatry, Psychology, and Medicine; Director, Sleep & Health Research Program, University of Arizona
Study Record Dates
First Submitted
November 8, 2019
First Posted
November 25, 2019
Study Start
November 18, 2019
Primary Completion
June 30, 2020
Study Completion
June 30, 2020
Last Updated
December 21, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share